Clinical trial
Short-term Dual Antiplatelet Therapy After Deployment of Bioabsorbable Polymer Everolimus-eluting Stent
NCT03447379 is registered in ClinicalTrials.gov with Gangnam Severance Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Short-term Dual Antiplatelet Therapy After Deployment of Bioabsorbable Polymer Everolimus-eluting Stent
- Lead sponsor
- Gangnam Severance Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 15, 2017
- Completion date
- August 17, 2022
- Enrollment
- 1,452 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.